Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients.

<h4>Background</h4>Metformin is proposed to have chemopreventive effect of various cancer currently. However, the anti-cancer effect of metformin for diabetic patients with hepatocellular carcinoma (HCC) undergoing liver resection remains unclear. The aim of our cohort study was to asses...

Full description

Bibliographic Details
Main Authors: Wei-Ru Cho, Chih-Chi Wang, Meng-Yun Tsai, Chen-Kai Chou, Yueh-Wei Liu, Yi-Ju Wu, Ming-Tsung Lin, Kuang-Den Chen, Ching-Hui Chuang, Pao-Yuan Huang, Tsung-Hui Hu, Ming-Chao Tsai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247231